XML 55 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Details) - USD ($)
 12 Months Ended
Mar. 13, 2024
Feb. 15, 2024
Jan. 24, 2024
Nov. 22, 2023
May 25, 2023
May 15, 2023
May 02, 2022
Mar. 31, 2024
Mar. 31, 2023
Feb. 29, 2024
Stockholders’ Equity [Line Items]                    
Shares authorized               100,000,000 50,000,000  
Purchase up additional shares   9,090,910 153,879       449,438      
common stock price per share (in Dollars per share)   $ 1.1               $ 1.1
Aggregate proceeds (in Dollars) $ 1,454,000     $ 6,500,000       $ 10,000,000    
Common stock purchase               32,464,000 10,949,000  
Cash fee               7.00%    
Pocket expenses (in Dollars)               $ 75,000    
Compensation services equal percentage       3.00%            
Net proceeds (in Dollars)     $ 278,000              
Aggregate gross proceeds (in Dollars)           $ 9,390,000        
Exercise price (in Dollars per share)           $ 1.22        
Expired term           5 years        
Paid cash fee percentage               7.00%    
Common stock par value (in Dollars per share)             $ 0.001 $ 0.001 $ 0.001  
Purchase price per share (in Dollars per share)             $ 4.45      
Purchase aggregate shares             1,348,000      
Pre funded warrant (in Dollars per share)             $ 4.44      
Exercise price (in Dollars per share)             $ 6.6      
Stock-based compensation (in Dollars)               $ 2,701,000 $ 2,724,000  
Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Purchase up additional shares           4,408,450        
Aggregate proceeds (in Dollars)               $ 142,000    
Exercise price per share (in Dollars per share)           $ 2.13        
Exercise price (in Dollars per share)               $ 1.32    
Underwriter common stock purchase warrants               709,760    
Private Placement Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Purchase up additional shares             1,438,202      
Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Stock-based compensation (in Dollars)               $ 1,429 11,264  
Estimate of Fair Value Measurement [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Stock-based compensation (in Dollars)               $ 1,400 $ 22,000  
Underwriting Agreement [Member]                    
Stockholders’ Equity [Line Items]                    
Purchase up additional shares               1,322,534    
Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Purchase up additional shares           8,816,900        
Common stock purchase               1,321,989    
Exercise price (in Dollars per share)             $ 0.01      
Common Stock [Member] | Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Exercise price (in Dollars per share)                 $ 0.01  
Common Stock [Member] | Minimum [Member]                    
Stockholders’ Equity [Line Items]                    
Shares authorized                   50,000,000
Common Stock [Member] | Maximum [Member]                    
Stockholders’ Equity [Line Items]                    
Shares authorized                   100,000,000
Over-Allotment Option [Member]                    
Stockholders’ Equity [Line Items]                    
Offering cost (in Dollars)               $ 125,000    
Over-Allotment Option [Member] | Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Purchase up additional shares               661,267    
Underwriting Agreement [Member]                    
Stockholders’ Equity [Line Items]                    
Aggregate proceeds (in Dollars)         $ 1,408,000          
Underwriter [Member] | Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Underwriter agents shares               604,623